Suchergebnisse - "Dejnirattisai, Wanwisa"

PubPharm (9)

1

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86

enthalten in: Nature communications | 2024

von Zhou, D. | Supasa, P. | Liu, C. | +14

2

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

enthalten in: JCI insight | 2022

von McNaughton, A. | Paton, R. | Edmans, M. | +54

3

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

enthalten in: Cell | 2022

von Nutalai, R. | Zhou, D. | Tuekprakhon, A. | +33

4

The antigenic anatomy of SARS-CoV-2 receptor binding domain

enthalten in: Cell | 2021

von Dejnirattisai, W. | Zhou, D. | Ginn, H. | +50

5

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection

enthalten in: Nature immunology | 2019

von Slon-Campos, J. | Dejnirattisai, W. | Jagger, B. | +10

CommentIn: Nat Immunol. 2019 Oct;20(10):1266-1268. - PMID 31520069

6

Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection

enthalten in: Nature immunology | 2017

von Fernandez, E. | Dejnirattisai, W. | Cao, B. | +10

ErratumIn: Nat Immunol. 2020 Mar;21(3):354. - PMID 32001822

7

Structural basis of potent Zika-dengue virus antibody cross-neutralization

enthalten in: Nature | 2016

von Barba-Spaeth, G. | Dejnirattisai, W. | Rouvinski, A. | +13

CommentIn: Nat Immunol. 2016 Aug 19;17 (9):1010-2. - PMID 27540984

8

Recognition determinants of broadly neutralizing human antibodies against dengue viruses

enthalten in: Nature | 2015

von Rouvinski, A. | Guardado-Calvo, P. | Barba-Spaeth, G. | +16

9

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

enthalten in: Nature medicine | 2003

von Mongkolsapaya, J. | Dejnirattisai, W. | Xu, X. | +11

CommentIn: Nat Med. 2003 Jul;9(7):820-2. - PMID 12835692

1
[1]